IJ Pharmaceutical Research
Scopus by Title (Ref)
1. The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system
- Li T. , et al.
2. Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review)
- Ye Z. , et al.
3. Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
- Sheikhi K. , et al.
4. Visualizing Sphingosine-1-Phosphate Receptor 1(S1P1) Signaling During Central Nervous System De- and Remyelination
- Hashemi E. , et al.
5. Forskolin, an Adenylcyclase/cAMP/CREB Signaling Activator Restoring Myelin-Associated Oligodendrocyte Destruction in Experimental Ethidium Bromide Model of Multiple Sclerosis
- Kapoor T. , et al.
6. Aspirin impacts on stem cells: Implications for therapeutic targets
- Zafarmand S.S. , et al.
7. Fingolimod increases oligodendrocytes markers expression in epidermal neural crest stem cells
- Pournajaf S. , et al.
8. Molecular effects of FDA-approved multiple sclerosis drugs on glial cells and neurons of the central nervous system
- De Kleijn K.M.A. , et al.
9. Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process
- Yazdi A. , et al.
10. Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm
- Hashemian M. , et al.